4 Results for "

PROTAC PI3Kα degrader-1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PROTAC PI3Kα degrader-1" in MCE Product Catalog:

Art. -Nr.: HY-174461
Target:  

PROTACs PI3K

Forschungsgebiete:  

Cancer

PROTAC PI3Kα degrader-1 is a PI3Kα PROTAC degrader that recruits CRBN, with a DC50 of 0.08 μM in T47D breast cancer cells. PROTAC PI3Kα degrader-1 inhibits the phosphorylation of AKT at the Ser 473 site in cancer cells and exhibits in vivo anticancer efficacy in xenograft models. PROTAC PI3Kα degrader-1 can be used in cancer-related research .
loading...
    loading...
Art. -Nr.: HY-182083
Target:  

PROTACs PI3K

Forschungsgebiete:  

Cancer

PROTAC PI3Kα/δ degrader-1 is an orally active PI3Kα/δ PROTAC degrader, with an IC50 of 0.34 nM for PI3Kα and 1.85 nM for PI3Kδ. PROTAC PI3Kα/δ degrader-1 inhibits the proliferation and migration of cancer cells, induces G1-phase cell cycle arrest and PI3Kα degradation. PROTAC PI3Kα/δ degrader-1 suppresses tumor growth in breast cancer xenograft mouse models. PROTAC PI3Kα/δ degrader-1 can be used for the research of breast cancer .
loading...
    loading...
Art. -Nr.: HY-174798
Forschungsgebiete:  

Cancer

PI3Kα Ligand-1 is the ligand for PI3Kα that can be used for synthesis of PROTACs, such as PI3Kα degrader-1 (HY-174461) .
loading...
    loading...
Art. -Nr.: HY-W940885
CAS. Nr.: 2716120-15-7
Forschungsgebiete:  

Cancer

Pomalidomide-NH-C13-OH is a synthesized E3 ligase ligand-linker conjugate that can be used for synthesis of PROTAC PI3Kα degrader-1 (HY-174461) .
loading...
    loading...